DRIM protein (299-307)

DRIM protein (299-307) is a synthetic peptide fragment corresponding to amino acid residues 299 to 307 of the DRIM protein sequence. As a defined peptide segment, it serves as a valuable tool in biochemical and molecular biology research, enabling the detailed study of protein structure-function relationships, post-translational modifications, and protein-protein interactions. The selection of this specific region within the DRIM protein allows researchers to interrogate the functional significance of localized domains, facilitating the elucidation of mechanisms underlying cellular signaling, regulation, and molecular recognition events.

Epitope mapping: The 299-307 fragment is frequently employed in epitope mapping studies to identify and characterize antibody binding sites within the DRIM protein. By utilizing this peptide as an antigen in immunoassays, researchers can determine the specificity of monoclonal or polyclonal antibodies, aiding in the development of diagnostic reagents or the validation of antibody-based detection techniques. Detailed mapping of immunogenic regions is essential for understanding immune recognition and for the rational design of peptide-based probes.

Protein interaction analysis: The defined sequence of the DRIM (299-307) peptide makes it an effective probe for investigating protein-protein interactions, particularly those mediated by short linear motifs or recognition domains. In pull-down assays, surface plasmon resonance, or other biophysical methods, the peptide can be used to assess binding affinities, delineate interaction interfaces, or screen for potential modulators. Such studies provide insights into the molecular networks and regulatory pathways in which the DRIM protein participates.

Post-translational modification research: The peptide segment representing residues 299-307 is suitable for in vitro modification studies, including phosphorylation, acetylation, or methylation assays. By subjecting the peptide to specific modifying enzymes, researchers can examine substrate specificity, map modification sites, and analyze the functional consequences of these biochemical changes. This approach supports a mechanistic understanding of how post-translational modifications influence DRIM protein activity and cellular function.

Peptide-based assay development: The synthetic DRIM (299-307) fragment can be incorporated into various assay platforms, such as enzyme-linked immunosorbent assays (ELISA), fluorescence polarization, or mass spectrometry-based detection methods. Its defined sequence and physicochemical properties enable the development of sensitive and selective analytical assays for quantifying protein interactions, monitoring enzymatic activity, or screening small-molecule inhibitors. Such assays are instrumental in both basic research and high-throughput screening applications.

Structural and conformational studies: The 299-307 peptide is a useful model for examining the secondary structure, folding propensity, or conformational stability of the corresponding region within the full-length DRIM protein. Techniques such as circular dichroism spectroscopy, nuclear magnetic resonance, or molecular dynamics simulations can be applied to the peptide to gain atomistic insights into its structural features. These studies contribute to a deeper understanding of the role that local structural elements play in the overall function and dynamics of the DRIM protein.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry